AGI Readiness for Healthcare: Clinical AI Governance as AI Capabilities Advance

The clinical AI governance paradox

Healthcare AI governance faces a paradox that is unique among sectors: in some specific domains, AI systems already outperform human specialists, and the performance gap is widening. Studies have demonstrated that AI systems match or exceed radiologist performance in detecting certain cancers, that AI ophthalmology tools detect diabetic retinopathy with accuracy comparable to specialist ophthalmologists, and that AI pathology systems identify specific cancer subtypes with precision that reduces inter-observer variability significantly. This creates a governance challenge that most clinical AI frameworks were not designed for: how do you maintain meaningful human oversight of an AI system when the human overseer is less accurate than the AI in the domain in question?

The governance response must be nuanced. The human oversight obligation in clinical AI is not primarily about ensuring human accuracy exceeds AI accuracy — it is about ensuring appropriate accountability for clinical decisions, maintaining patient rights to understand and contest decisions made about them, and preserving the clinical judgment that AI systems cannot provide: understanding the whole patient, applying values to clinical trade-offs, and navigating the complex social and contextual factors that affect health outcomes. These are governance requirements that persist regardless of AI diagnostic accuracy.

Automation bias: the documented governance failure

The most well-documented clinical AI governance failure mode is automation bias — the tendency of human operators to defer to automated systems even when those systems are wrong. In clinical AI contexts, automation bias means that clinicians who are presented with AI recommendations are more likely to follow those recommendations without independent assessment, even in cases where the AI is incorrect. The counterintuitive finding from clinical AI research: teams with access to AI decision support that are not specifically trained to critically evaluate AI recommendations sometimes produce worse outcomes than teams without AI support, because the AI provides confident incorrect recommendations that the human clinician does not override.

Effective clinical AI governance must address automation bias directly, not assume that human oversight will be effective by default. This means: training clinicians specifically in how to critically evaluate AI recommendations, not just how to use the AI tool; designing clinical workflows that require independent human assessment before AI recommendations are acted upon; monitoring for patterns of uncritical AI deference in clinical audit; and designing AI interfaces that present uncertainty and limitations prominently rather than projecting false confidence.